PHRM PharmaTher Holdings Ltd.

0.0315USD0.0450 CAD · CNQ0.00%Mkt Cap: 2.86M USDP/E: —

PharmaTher Holdings Ltd., a specialty pharmaceutical and technology company, develops, acquires, and commercializes pharmaceutical products. The company's product pipeline includes KETARX, a ketamine hydrochloride inject…

Key Statistics

Company
Market Cap2.86M USD
Enterprise Value2.32M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-426.72K USD
Revenue/Share—
Last Price0.0315 USD
Fiscal Year EndMay 2026
MR QuarterAug 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISINCA71716H1082
Valuation
P/E (Trailing)—
P/E (Forward)-0.41
PEG—
EV/EBITDA—
EV/Revenue—
P/S—
P/B11.25
EPS (TTM)0.00 USD
EPS (Forward)-0.08 USD
52W Range
0.02801% of range0.2901
52W High0.2901 USD
52W Low0.0280 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-99.56%
ROA-54.39%
ROIC—
ROCE-137.98%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-339.04K USD
CapEx (TTM)—
FCF Margin—
FCF Yield-6.32%
Net Debt-538.74K USD
Net Debt/EBITDA—
Net Debt/FCF—
Balance Sheet
Debt/Equity—
Current Ratio1.34
Quick Ratio1.34
Book Value/Sh0.0028 USD
Cash/Share0.0056 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.91.02M
Float73.51M
Insiders18.74%
Institutions0.00%
Short Interest
Short Ratio0.4d
Short % Out.0.02%
Shares Short14.13K
Short (prev mo.)11.38K
Technical
SMA 500.0373 (-15.7%)
SMA 2000.0442 (-28.8%)
Beta2.34
S&P 52W Chg12.00%
Avg Vol (30d)36.93K
Avg Vol (10d)15.45K
Technical Indicators
RSI (14)36.5
MACD-0.0024
MACD Signal-0.0016
MACD Hist.-0.0009
BB Upper0.0419 USD
BB Middle0.0362 USD
BB Lower0.0305 USD
BB Width31.41%
ATR (14)0.0026 USD
Vol Ratio (20d)4.79x

About PharmaTher Holdings (CNSX: PHRM)

›

PharmaTher Holdings (CNSX: PHRM) is listed on the Canadian Securities Exchange, where its shares trade in CAD. It belongs to the Biotechnology industry, part of the Healthcare sector.

The shares were at 0.0450 CAD on 19 November 2026, down 88.2% over 52 weeks. Its 52-week range is 0.0400 CAD to 0.4150 CAD: the price is 89.2% below the high and 12.5% above the low.

Its market capitalisation is 4.10M CAD.

PharmaTher Holdings reports return on equity of -99.6% and an operating margin of 0.0%.

It holds more cash than debt, a net cash position of 770.67K CAD. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health.